Results 211 to 220 of about 342,266 (343)
Functional segregation of hepatic receptors for asialoglycoproteins during endocytosis.
Richard J. Stockert+3 more
openalex +1 more source
Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells [PDF]
Espen Stang+4 more
openalex +1 more source
A hollow nanomotor (PM‐HMSN/Arg) propelled by ultrasound‐triggered nitric oxide (NO) was developed. The nanomotor employs a “tethering‐relaxing‐drilling” mechanism to overcome biological barriers, enabling multimodal theranostics of cancer with deep penetration and extended lifetime.
Xue Xu+7 more
wiley +1 more source
Characterizing the Membrane Assembly of ASGPR Related to Mediated Endocytosis Using TriGalNAc-Probe-Based Super-Resolution Imaging. [PDF]
Chen J+6 more
europepmc +1 more source
Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis. [PDF]
Luis S. Mayorga+7 more
openalex +1 more source
In this study, a novel mechanism is unveiled by which ADD1, acting as a molecular switch, coordinates actin branch dynamics and the transport of endocytic viruses and cargoes. Phosphorylation of ADD1 at Ser726 reduces actin branch density, enhancing endosome fusion and attachment to microtubules.
Meijun Jiang+10 more
wiley +1 more source
Prelysosomal and lysosomal connections between autophagy and endocytosis [PDF]
Paul B. Gordon, H Høyvik, Per O. Seglen
openalex +1 more source
This work reports a mitochondria‐targeted nanozyme platform, MIL‐Cu1.8S‐TPP/FA, which induces potent cuproptosis via localized delivery of Cu1.8S nanodots to mitochondria. Surface‐anchoring these nanodots onto MIL‐88B metal‐organic frameworks enhances both passive and active tumor targeting.
Chenguang Liu+8 more
wiley +1 more source
Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors. [PDF]
W Lütz+3 more
openalex +1 more source
This review compares clinical outcomes, translational progress, and global funding trends across cancer phototherapies—photodynamic, photothermal, and photoimmunotherapy—and conventional immunotherapy. It highlights differences in treatment efficacy, clinical trial status, financial investment, and regulatory challenges, providing a comprehensive ...
Deepak S. Chauhan+6 more
wiley +1 more source